K. Kubica and A. Mazurek, “VEMURAFENIB AS A SELECTIVE INHIBITOR OF THE SERINE/THREONINE-PROTEIN KINASE B-RAF, USED IN THE TREATMENT OF MELANOMA”, Prosp. Pharm. Sc., vol. 14, no. 8, pp. 52–56, Dec. 2016.